X-18507090-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_001323289.2(CDKL5):c.-7T>G variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.00000655 in 1,068,829 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000065 ( 0 hom. 4 hem. )
Consequence
CDKL5
NM_001323289.2 5_prime_UTR_premature_start_codon_gain
NM_001323289.2 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.95
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant X-18507090-T-G is Benign according to our data. Variant chrX-18507090-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 3039544.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Hemizygotes in GnomAdExome4 at 4 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKL5 | NM_001323289.2 | c.-7T>G | 5_prime_UTR_premature_start_codon_gain_variant | 2/18 | ENST00000623535.2 | NP_001310218.1 | ||
CDKL5 | NM_001323289.2 | c.-7T>G | 5_prime_UTR_variant | 2/18 | ENST00000623535.2 | NP_001310218.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKL5 | ENST00000623535 | c.-7T>G | 5_prime_UTR_premature_start_codon_gain_variant | 2/18 | 1 | NM_001323289.2 | ENSP00000485244.1 | |||
CDKL5 | ENST00000623535 | c.-7T>G | 5_prime_UTR_variant | 2/18 | 1 | NM_001323289.2 | ENSP00000485244.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183223Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67677
GnomAD3 exomes
AF:
AC:
2
AN:
183223
Hom.:
AF XY:
AC XY:
1
AN XY:
67677
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000655 AC: 7AN: 1068829Hom.: 0 Cov.: 25 AF XY: 0.0000118 AC XY: 4AN XY: 338671
GnomAD4 exome
AF:
AC:
7
AN:
1068829
Hom.:
Cov.:
25
AF XY:
AC XY:
4
AN XY:
338671
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CDKL5-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 25, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at